Immunogenicity 13756
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
MUC3A
Transcript ID
uc003uxl.1
HLA INFO
C*12:03
TCR INFO
No TCR info found!
Full length protein sequence (776 aa)
MSTVR
1
MTLRI
6
TENTP
11
ISSFS
16
TSIVV
21
IPETP
26
TQTPP
31
VLTSA
36
TGTQT
41
SPAPT
46
TVTFG
51
STDSS
56
TSTLH
61
TLTPS
66
TALST
71
IVSTS
76
QVPIP
81
STHSS
86
TLQTT
91
PSTPS
96
LQTSL
101
TSTSE
106
FTTES
111
FTRGS
116
TSTNA
121
ILTSF
126
STIIW
131
SSTPT
136
IIMSS
141
SPSSA
146
SITPV
151
FSTTI
156
HSVPS
161
SPYIF
166
STENV
171
GSASI
176
TGFPS
181
LSSSA
186
TTSTS
191
STSSS
196
LTTAL
201
TEITP
206
FSYIS
211
LPSTT
216
PCPGT
221
ITITI
226
VPASP
231
TDPCV
236
EMDPS
241
TEATS
246
PPTTP
251
LTVFP
256
FTTEM
261
VTCPT
266
SISIQ
271
TTLTT
276
YMDTS
281
SMMPE
286
SESSI
291
SPNAS
296
SSTGT
301
GTVPT
306
NTVFT
311
STRLP
316
TSETW
321
LSNSS
326
VIPLP
331
LPGVS
336
TIPLT
341
MKPSS
346
SLPTI
351
LRTSS
356
KSTHP
361
SPPTT
366
RTSET
371
PVATT
376
QTPTT
381
LTSRR
386
TTRIT
391
SQMTT
396
QSTLT
401
TTAGT
406
CDNGG
411
TWEQG
416
QCACL
421
PGFSG
426
DRCQL
431
QTRCQ
436
NGGQW
441
DGLKC
446
QCPST
451
FYGSS
456
CEFAV
461
EQVDL
466
DVVET
471
EVGME
476
VSVDQ
481
QFSPD
486
LNDNT
491
SQAYR
496
DFNKT
501
FWNQM
506
QKIFA
511
DMQGF
516
TFKGV
521
EILSL
526
RNGSI
531
VVDYL
536
VLLEM
541
PFSPQ
546
LESEY
551
EQVKT
556
TLKEG
561
LQNAS
566
QDANS
571
CQDSQ
576
TLCFK
581
PDSIK
586
VNNNS
591
KTELT
596
PEAIC
601
RRAAP
606
TGYEE
611
FYFPL
616
VEATR
621
LRCVT
626
KCTSG
631
VDNAI
636
DCHQG
641
QCVLE
646
TSGPA
651
CRCYS
656
TDTHW
661
FSGPR
666
CEVAV
671
HWRAL
676
VGGLT
681
AGAAL
686
LVLLL
691
LALGV
696
RAVRS
701
GWWGG
706
QRRGR
711
SWDQD
716
RKWFE
721
TWDEE
726
VVGTF
731
SNWGF
736
EDDGT
741
DKDTN
746
FHVAL
751
ENVDT
756
TMKVH
761
IKRPE
766
MTSSS
771
V
776
Mutation Information
DNA mutation:
None
Peptide Range:
6 ~ 30
Mut AA position:
18 (13 in Wild Type peptide)
Alignment
Wild Type:
"MTLRITENTPISSFSTSIVVIPETP
||||||||||||.||||||||||||
Mutant:
MTLRITENTPISFFSTSIVVIPETP"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) MUC3A
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay